Hybribio
2 known investors
Find your way into Hybribio
Sign up to see every warm intro you have to Hybribio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Hybribio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Guangdong Hybribio Biotech is a Chinese developer and supplier of nucleic acid molecular diagnostic products, focused on the R&D, production, and sale of molecular diagnostic reagents and instruments, including HPV genotyping detection kits and gene chips. The company also operates a healthcare arm, including a specialty hospital in Chaozhou offering blood purification, health screening, and chronic disease management services.
Investors · 2
Fortune Venture CapitalreportedShenzhen
How we know: the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Hybribio do?
- Guangdong Hybribio Biotech is a Chinese developer and supplier of nucleic acid molecular diagnostic products, focused on the R&D, production, and sale of molecular diagnostic reagents and instruments, including HPV genotyping detection kits and gene chips. The company also operates a healthcare arm, including a specialty hospital in Chaozhou offering blood purification, health screening, and chronic disease management services.
- Who are Hybribio's investors?
- Hybribio's investors include Pan-Lin Capital, Fortune Venture Capital.
